Intravenous (IV) Therapy and Vein Access: Global Markets

  • ID: 4327625
  • Report
  • Region: Global
  • 227 Pages
  • BCC Research
15 % OFF
until Jun 30th 2018
1 of 6
The Global Intravenous (IV) Therapy and Vein Access Market Should Reach $29 Billion by 2021 from $21.6 Billion in 2016 at a CAGR of 6.1%, from 2016 to 2021

FEATURED COMPANIES

  • Angiodynamics Inc.
  • C.R. Bard, Inc.
  • Debiotech S. A.
  • Insulet Corp.
  • Micrel Medical Devices SA
  • Tandem Diabetes Care Inc.
  • MORE

Report Includes

  • An overview of the global markets and technologies for intravenous (IV) therapy and vein access.
  • Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
  • Detailed information on the main categories for IV therapy, including ambulatory infusion pumps, central venous access devices, diabetes insulin-infusion pumps, enteral feeding pumps and tubes, implantable pumps, large-volume infusion pumps, peripheral venous access devices, and syringe infusion pumps.
  • Identification of current products on the market.
  • Assessments of the competitive landscape and competitor market shares.
  • Profiles of the company related to the industry.

Report Scope

Growing emphasis on cost-effectiveness and cost-containment at health care facilities along with technological advances have enabled the safe and effective use of IV therapies. This is driving steady growth of the IV therapy and vein access devices market. This report focuses on the global market of IV therapy and vein access devices and provides an updated review that includes applications in various care facility settings.

The scope of this study encompasses different types of IV solutions and devices used for therapeutic purposes. BCC Research studied and analyzed the market for key components including different types of intravenous solutions and sets, infusion pumps and vein access devices (IV catheters). This report covers the associated regulatory aspects such as innovations and technological improvements (patents and approvals), latest trends, preferences and progress in the field of IV therapy. In addition, the study also covers the market projections, market leaders and market shares for the global IV therapy market.

The geographical regions covered in the report are North America, Europe and emerging markets. The emerging markets cover countries such as India, China, Japan, South Korea, Taiwan, Africa, Australia, New Zealand, etc.

This report also contains relevant patent analysis and comprehensive company profiles for leaders in the IV therapy and vein access devices industry. The market is dominated by a few major players including B. Braun Melsungen AG; Baxter International Inc.; Becton Dickinson and Co. (CareFusion Corp.); C. R. Bard, Inc.; Fresenius Kabi AG; Hospira Inc. (now part of ICU Medical Inc.); Medtronic plc.; Smiths Group plc. (Smiths Medical) and Teleflex Inc.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Angiodynamics Inc.
  • C.R. Bard, Inc.
  • Debiotech S. A.
  • Insulet Corp.
  • Micrel Medical Devices SA
  • Tandem Diabetes Care Inc.
  • MORE

1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Intended Audience
  • Scope of the Report
  • Information Sources
  • Methodology
  • Geographic Breakdown

2: Summary and Highlights

  • Table Summary : Global Market for IV Therapy and Vein Access, by Product Type, Through 2021
  • Figure Summary : Global Market for IV Therapy and Vein Access, by Product Type, 2014-2021

3: Intravenous Therapy Overview

  • The Human Circulatory System
  • Definition of Infusion Therapy
  • Definition of Intravenous Therapy
  • Types of IV Infusion
  • Methods of IV Infusion
  • Advantages and Disadvantages of Intravenous (IV) Therapy
  • Historical Development of Intravenous Therapy
  • General Principles of IV Therapy
  • IV Solutions
  • Venous Access Devices (IV Catheters)

4: Regulatory Aspects

  • FDA Recalls and Safety Alerts
  • Safety Alerts for IV Solution
  • Recalls and Safety Communications for IV Devices (Infusion Pumps and IV Catheters)
  • New Approvals

5: New Developments/Technological Innovations

  • New Developments in the Field of IV Solutions and Sets
  • New Developments in the Field of IV Infusion Pumps
  • New Developments in the Field of IV Catheters

6: Market Analysis

  • IV Therapy and Vein Access Market by Product Types
  • IV Therapy and Venous Access Device Market by Region

7: Industry Structure

  • IV Solutions and Sets
  • Infusion Pumps
  • Vein Access Devices (IV Catheters)

8: Market by Application

  • Market Overview
  • Market Revenue
  • Market Share

9: Patent Analysis

  • Award Year
  • Product Type
  • Company
  • Country Breakdown
  • Assignee

10: Current Outlook

  • Factors Affecting Intravenous (IV) Therapy and Venous Access Devices Market
  • Collaborations - Mergers and Acquisitions

11: Company Profiles

  • Angel Electronic Equipment Co. Ltd.
  • Angiodynamics Inc.
  • Animas Corp.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson And Company
  • Caesarea Medical Electronics Ltd.
  • Cequr SA
  • Codman & Shurtleff Inc.
  • Cook Medical Inc.
  • C.R. Bard, Inc.
  • Debiotech S. A.
  • Edwards Lifesciences Corp.
  • Fresenius Kabi AG
  • Halyard Health, Inc.
  • Health Line International Corp.
  • Icu Medical Inc.
  • Insulet Corp.
  • Iradimed Corp.
  • Medical Components Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Roche Diagnostics
  • Smiths Medical
  • Sooil Developments Co., Ltd
  • Tandem Diabetes Care Inc.
  • Teleflex Inc.
  • Terumo Medical Corp.
  • Valeritas Inc.
  • Vygon SA
  • Zyno Medical Llc

12: Appendix: Abbreviations

  • Table 97 : Abbreviations Used in the Report
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Angiodynamics Inc.
  • C.R. Bard, Inc.
  • Debiotech S. A.
  • Insulet Corp.
  • Micrel Medical Devices SA
  • Tandem Diabetes Care Inc.
  • MORE

Analyst Credentials:

Shalini Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Note: Product cover images may vary from those shown
5 of 6
  • Angel Electronic Equipment Co. Ltd.
  • Angiodynamics Inc.
  • Animas Corp.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson And Company
  • Caesarea Medical Electronics Ltd.
  • Cequr SA
  • Codman & Shurtleff Inc.
  • Cook Medical Inc.
  • C.R. Bard, Inc.
  • Debiotech S. A.
  • Edwards Lifesciences Corp.
  • Fresenius Kabi AG
  • Halyard Health, Inc.
  • Health Line International Corp.
  • Icu Medical Inc.
  • Insulet Corp.
  • Iradimed Corp.
  • Medical Components Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Moog Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Roche Diagnostics
  • Smiths Medical
  • Sooil Developments Co., Ltd
  • Tandem Diabetes Care Inc.
  • Teleflex Inc.
  • Terumo Medical Corp.
  • Valeritas Inc.
  • Vygon SA
  • Zyno Medical Llc
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll